Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Net Income towards Common Stockholders (2016 - 2025)

CorMedix (CRMD) has disclosed Net Income towards Common Stockholders for 14 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 56.9% to $14.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $165.1 million through Dec 2025, up 14429.32% year-over-year, with the annual reading at $163.1 million for FY2025, 14253.43% up from the prior year.
  • Net Income towards Common Stockholders hit $14.0 million in Q4 2025 for CorMedix, down from $108.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $108.5 million in Q3 2025 to a low of -$14.5 million in Q1 2024.
  • Historically, Net Income towards Common Stockholders has averaged $7.6 million across 5 years, with a median of $4.6 million in 2021.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 250.96% in 2023 and later skyrocketed 4008.55% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$9.7 million in 2021, then grew by 15.08% to -$8.2 million in 2022, then decreased by 18.7% to -$9.7 million in 2023, then skyrocketed by 433.84% to $32.5 million in 2024, then crashed by 56.9% to $14.0 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for CRMD at $14.0 million in Q4 2025, $108.5 million in Q3 2025, and $21.9 million in Q2 2025.